Vestcor Inc’s Haemonetics HAE Stock Holding History

Vestcor Inc’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$143K	Sell	1,902 -6,393	-77%	-$411K	﹤0.01%	1095
2026 Q1	$468K	Buy	8,295 +4,516	+120%	+$294K	0.01%	753
2025 Q4	$303K	Hold	3,779	–	–	0.01%	879
2025 Q3	$184K	Hold	3,779	–	–	0.01%	997
2025 Q2	$282K	Hold	3,779	–	–	0.01%	890
2025 Q1	$240K	Sell	3,779 -3,512	-48%	-$239K	0.01%	914
2024 Q4	$569K	Hold	7,291	–	–	0.02%	634
2024 Q3	$586K	Hold	7,291	–	–	0.02%	637
2024 Q2	$603K	Hold	7,291	–	–	0.02%	598
2024 Q1	$622K	Sell	7,291 -2,343	-24%	-$184K	0.02%	569
2023 Q4	$824K	Hold	9,634	–	–	0.03%	494
2023 Q3	$863K	Buy	9,634 +3,779	+65%	+$337K	0.03%	456
2023 Q2	$498K	Hold	5,855	–	–	0.02%	607
2023 Q1	$485K	Buy	+5,855	New	+$474K	0.02%	641
2020 Q2	–	Sell	-4,797	Closed	-$478K	–	903
2020 Q1	$478K	Sell	4,797 -533	-10%	-$57.8K	0.03%	411
2019 Q4	$612K	Buy	+5,330	New	+$645K	0.03%	432

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vestcor Inc's HAE Position: Q2 2026 in Review

Vestcor Inc reduced its Haemonetics (HAE) stake by 77% in Q2 2026, selling an estimated $411K and leaving 1,902 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #1095.

Vestcor Inc first reported a position in HAE in Q4 2019 and has held it in 16 quarters since. The position peaked at $863K in Q3 2023. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Vestcor Inc held 1,902 shares of Haemonetics worth $143K as of Q2 2026.
Vestcor Inc sold 6,393 Haemonetics shares in Q2 2026, an estimated $411K.
Haemonetics made up ﹤0.01% of Vestcor Inc's portfolio in Q2 2026, its #1095 holding.
Vestcor Inc first reported a position in Haemonetics in Q4 2019 and has held it in 16 quarters since.
Vestcor Inc's Haemonetics position peaked at $863K in Q3 2023.
329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Vestcor Inc's 13F filing for Q2 2026, filed 11 Aug 2026.